Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
Bossa F, Carparelli S, Latiano A, Palmieri O, Tavano F, Panza A, Pastore M, Marseglia A, D'Altilia M, Latiano T, Corritore G, Martino G, Nardella M, Guerra M, Terracciano F, Sacco M, Perri F, Andriulli A. Bossa F, et al. Among authors: guerra m. Dig Liver Dis. 2021 Mar;53(3):277-282. doi: 10.1016/j.dld.2020.12.120. Epub 2021 Jan 6. Dig Liver Dis. 2021. PMID: 33423942 Free PMC article.
False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy.
Latiano A, Tavano F, Panza A, Palmieri O, Niro GA, Andriulli N, Latiano T, Corritore G, Gioffreda D, Gentile A, Fontana R, Guerra M, Biscaglia G, Bossa F, Carella M, Miscio G, di Mauro L. Latiano A, et al. Among authors: guerra m. Int J Infect Dis. 2021 Mar;104:159-163. doi: 10.1016/j.ijid.2020.12.067. Epub 2020 Dec 28. Int J Infect Dis. 2021. PMID: 33383223 Free PMC article.
Worse impact of second wave COVID-19 pandemic in adults but not in children with inflammatory bowel disease: an Italian single tertiary center experience.
Carparelli S, Pastore MR, Valvano MR, Marseglia A, Latiano A, Palmieri O, Guerra M, Martino G, Perri F, Bossa F. Carparelli S, et al. Among authors: guerra m. Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2744-2747. doi: 10.26355/eurrev_202103_25437. Eur Rev Med Pharmacol Sci. 2021. PMID: 33829460 Free article.
Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience.
Parente P, Maiorano BA, Ciardiello D, Cocomazzi F, Carparelli S, Guerra M, Ingravallo G, Cazzato G, Carosi I, Maiello E, Bossa F. Parente P, et al. Among authors: guerra m. Diagnostics (Basel). 2022 Mar 11;12(3):685. doi: 10.3390/diagnostics12030685. Diagnostics (Basel). 2022. PMID: 35328239 Free PMC article.
Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey.
Bossa F, Valvano MR, Vetrone LM, Guerra M, Lopetuso LR, Carparelli S, Mignini I, Cocomazzi F, Napolitano D, Costantino A, Caprioli F, Gasbarrini A, Perri F, Papa A. Bossa F, et al. Among authors: guerra m. Eur Rev Med Pharmacol Sci. 2022 Oct;26(19):7277-7284. doi: 10.26355/eurrev_202210_29921. Eur Rev Med Pharmacol Sci. 2022. PMID: 36263539 Free article.
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.
Macaluso FS, Principi M, Facciotti F, Contaldo A, Todeschini A, Saibeni S, Bezzio C, Castiglione F, Nardone OM, Spagnuolo R, Fantini MC, Riguccio G, Conforti S, Caprioli F, Viganò C, Felice C, Fiorino G, Correale C, Bodini G, Milla M, Scardino G, Vernero M, Desideri F, Bossa F, Guerra M, Ventimiglia M, Casà A, Rizzo G, Orlando A; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Macaluso FS, et al. Among authors: guerra m. Inflamm Bowel Dis. 2024 May 2;30(5):854-858. doi: 10.1093/ibd/izad118. Inflamm Bowel Dis. 2024. PMID: 37390400 No abstract available.
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study.
Ribaldone DG, Parisio L, Variola A, Bossa F, Castiglione F, Marzo M, Piazza N, Aratari A, Savarino EV, Bodini G, Mastronardi M, Micheli F, Mazzuoli S, Ascolani M, Viganò C, Cappello M, Bezzio C, Ciccocioppo R, Scardino G, Sarli E, Pugliese D, Scaldaferri F, Napolitano D, Todeschini A, Geccherle A, Colaci N, Guerra M, Annese M, Testa A, Caiazzo A, Conforti FS, Festa S, Lorenzon G, Marra A, Magiotta A, Baccini F, Amato A, Poshnjari A, Vernero M, Caprioli F, Caviglia GP; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). Ribaldone DG, et al. Among authors: guerra m. Dig Liver Dis. 2024 Jan;56(1):77-82. doi: 10.1016/j.dld.2023.07.011. Epub 2023 Jul 19. Dig Liver Dis. 2024. PMID: 37474412
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study.
Saibeni S, Bezzio C, Bossa F, Privitera AC, Marchi S, Roselli J, Mazzuoli S, Geccherle A, Soriano A, Principi MB, Viola A, Sarpi L, Cappello M, D'Incà R, Mastronardi M, Bodini G, Guerra M, Benedetti A, Romano M, Cicala M, Di Sabatino A, Scaldaferri F, De Rosa T, Giardino AM, Germano V, Orlando A, Armuzzi A. Saibeni S, et al. Among authors: guerra m. Dig Liver Dis. 2024 Jan;56(1):83-91. doi: 10.1016/j.dld.2023.07.031. Epub 2023 Aug 12. Dig Liver Dis. 2024. PMID: 37574431 Free article.
1,596 results